Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: G
Results 31 - 40 of 306 shown below

  • Galectin-3

    J F Collet, I Hurbain, C Prengel, O Utzmann, F Scetbon, J F Bernaudin and A Fajac

    Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples

    advance online publication, 2005-10-25 00:00:00.000;

    doi:10.1038/sj.bjc.6602822

    Abstract | Full article | PDF

  • A Carpi, A G Naccarato, G Iervasi, A Nicolini, G Bevilacqua, P Viacava, P Collecchi, L Lavra, C Marchetti, S Sciacchitano and A Bartolazzi

    Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology

    advance online publication, 2006-06-27 00:00:00.000;

    doi:10.1038/sj.bjc.6603232

    Abstract | Full article | PDF

  • C Paret, D Hildebrand, J Weitz, A Kopp-Schneider, A Kuhn, A Beer, R Hautmann and M Zöller

    C4.4A as a candidate marker in the diagnosis of colorectal cancer

    advance online publication, 2007-10-02 00:00:00.000;

    doi:10.1038/sj.bjc.6604012

    Abstract | Full article | PDF

  • gall bladder cancer

    D C Doval, J S Sekhon, S K Gupta, J Fuloria, V K Shukla, S Gupta and B S Awasthy

    A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer

    advance online publication, 2004-03-16 00:00:00.000;

    doi:10.1038/sj.bjc.6601736

    Abstract | Full article | PDF

  • M J Grainge, J West, M Solaymani-Dodaran, G P Aithal and T R Card

    The antecedents of biliary cancer: a primary care case–control study in the United Kingdom

    advance online publication, 2008-11-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604765

    Abstract | Full article | PDF

  • gallbladder cancer

    S C Larsson and A Wolk

    Obesity and the risk of gallbladder cancer: a meta-analysis

    advance online publication, 2007-03-20 00:00:00.000;

    doi:10.1038/sj.bjc.6603703

    Abstract | Full article | PDF

  • J W Valle, H Wasan, P Johnson, E Jones, L Dixon, R Swindell, S Baka, A Maraveyas, P Corrie, S Falk, S Gollins, F Lofts, L Evans, T Meyer, A Anthoney, T Iveson, M Highley, R Osborne and J Bridgewater

    Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

    doi:10.1038/sj.bjc.6605211

    Abstract | Full article | PDF

  • A D Wagner, P Buechner-Steudel, M Moehler, H Schmalenberg, R Behrens, J Fahlke, A Wein, S Behl, O Kuss, G Kleber and W E Fleig

    Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials

    advance online publication, 2009-11-10 00:00:00.000;

    doi:10.1038/sj.bjc.6605377

    Abstract | Full article | PDF

  • T Oshikiri, Y Hida, M Miyamoto, H Hashida, K Katoh, M Suzuoki, Y Nakakubo, K Hiraoka, T Shinohara, T Itoh, S Kondo and H Katoh

    RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer

    doi:10.1054/bjoc.2001.2192

    Abstract | Full article | PDF

  • gallbladder carcinoma

    F Eckel and R M Schmid

    Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

    advance online publication, 2007-02-27 00:00:00.000;

    doi:10.1038/sj.bjc.6603648

    Abstract | Full article | PDF

  • O Nehls, H Oettle, J T Hartmann, R-D Hofheinz, H G Hass, M S Horger, U Koppenhöfer, A Hochhaus, J Stieler, J Trojan, M Gregor and B Klump

    Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial

    advance online publication, 2008-01-08 00:00:00.000;

    doi:10.1038/sj.bjc.6604178

    Abstract | Full article | PDF

  • gallstones

    E S Schernhammer, D S Michaud, M F Leitzmann, E Giovannucci, G A Colditz and C S Fuchs

    Gallstones, cholecystectomy, and the risk for developing pancreatic cancer

    doi:10.1038/sj.bjc.6600193

    Abstract | Full article | PDF

  • E S Schernhammer, M F Leitzmann, D S Michaud, F E Speizer, E Giovannucci, G A Colditz and C S Fuchs

    Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas

    doi:10.1038/sj.bjc.6600661

    Abstract | Full article | PDF

  • A Altieri, C Pelucchi, R Talamini, C Bosetti, S Franceschi and C La Vecchia

    Cholecystectomy and the risk of colorectal cancer in Italy

    advance online publication, 2004-03-16 00:00:00.000;

    doi:10.1038/sj.bjc.6601721

    Abstract | Full article | PDF

  • A W Hsing, Y-T Gao, T-Q Han, A Rashid, L C Sakoda, B-S Wang, M-C Shen, B-H Zhang, S Niwa, J Chen and J F Fraumeni

    Gallstones and the risk of biliary tract cancer: a population-based study in China

    advance online publication, 2007-11-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604047

    Abstract | Full article | PDF

  • A W Hsing, L C Sakoda, A Rashid, J Chen, M C Shen, T Q Han, B S Wang and Y T Gao

    Body size and the risk of biliary tract cancer: a population-based study in China

    doi:10.1038/sj.bjc.6604616

    Abstract | Full article | PDF

  • C de Martel, M Plummer, J Parsonnet, L-J van Doorn and S Franceschi

    Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract

    advance online publication, 2008-11-25 00:00:00.000;

    doi:10.1038/sj.bjc.6604780

    Abstract | Full article | PDF

  • W H Chow, C Johansen, G Gridley, L Mellemkjær and J F Fraumeni Jr

    Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas

    doi:10.1038/sj.bjc.6690101

    Abstract | Full article | PDF

  • GalNAc glycoproteins

    S A Brooks, D M S Hall and I Buley

    GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane

    doi:10.1054/bjoc.2001.2028

    Abstract | Full article | PDF

  • GalNAc-T3

    H Dosaka-Akita, I Kinoshita, K Yamazaki, H Izumi, T Itoh, H Katoh, M Nishimura, K Matsuo, Y Yamada and K Kohno

    N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers

    doi:10.1038/sj.bjc.6600536

    Abstract | Full article | PDF

  • C Gu, T Oyama, T Osaki, J Li, M Takenoyama, H Izumi, K Sugio, K Kohno and K Yasumoto

    Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence

    doi:10.1038/sj.bjc.6601531

    Abstract | Full article | PDF

  • GALT3

    N Tsuda, Y Nonaka, S Shichijo, A Yamada, M Ito, Y Maeda, M Harada, T Kamura and K Itoh

    UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour

    doi:10.1038/sj.bjc.6600593

    Abstract | Full article | PDF

  • gamma dose rate

    The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 2: gamma radiation

    doi:10.1038/sj.bjc.6600277

    Abstract | Full article | PDF

  • gamma-glutamyl transpeptidase

    Y Zlotnik, M Patya, A Vanichkin and A Novogrodsky

    Tyrphostins reduce chemotherapy-induced intestinal injury in mice: assessment by a biochemical assay

    advance online publication, 2005-01-18 00:00:00.000;

    doi:10.1038/sj.bjc.6602324

    Abstract | Full article | PDF